Neuland to launch commercial peptide facility in Hyderabad as global capacity tightens
The first of four planned modules at the new plant is expected to come online by summer 2026
The first of four planned modules at the new plant is expected to come online by summer 2026
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
Nadda underlined that India’s policy framework is aligned with this transformation
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
Subscribe To Our Newsletter & Stay Updated